ID: ALA2205125

Max Phase: Preclinical

Molecular Formula: C32H40N2O5

Molecular Weight: 532.68

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(-c2ccc(C(C(=O)NC(C)(C)C)N(C(=O)CCc3ccc(O)c(O)c3)C(C)(C)C)cc2)cc1

Standard InChI:  InChI=1S/C32H40N2O5/c1-31(2,3)33-30(38)29(24-12-10-22(11-13-24)23-14-16-25(39-7)17-15-23)34(32(4,5)6)28(37)19-9-21-8-18-26(35)27(36)20-21/h8,10-18,20,29,35-36H,9,19H2,1-7H3,(H,33,38)

Standard InChI Key:  QGMMFKZFRXRRCM-UHFFFAOYSA-N

Associated Targets(non-human)

Inhibitor of nuclear factor kappa-B kinase subunit beta 81 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MAP kinase p38 226 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 532.68Molecular Weight (Monoisotopic): 532.2937AlogP: 5.99#Rotatable Bonds: 8
Polar Surface Area: 99.10Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.29CX Basic pKa: CX LogP: 5.52CX LogD: 5.51
Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.31Np Likeness Score: -0.61

References

1. Kravchenko VV, Gloeckner C, Stowe GN, Kang YJ, Tobias PS, Mathison JC, Ulevitch RJ, Kaufmann GF, Janda KD..  (2012)  The use of small molecule probes to study spatially separated stimulus-induced signaling pathways.,  22  (5): [PMID:22300658] [10.1016/j.bmcl.2012.01.024]

Source